- ISIN
- US7431854808
- CUSIP
- 743185480
- Issuer
- ProFunds
- Inception Date
- Jun 18, 2000
- Category
- Leveraged Equities
- Min. Investment
- $15,000
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Large-Cap
- Asset Class Style
- Blend
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BIPIX Performance Chart
ProFunds Biotechnology UltraSector Fund (BIPIX) is up 10.1% since the beginning of the year. BIPIX is currently trading at $74 per share. Investors who bought $1,000 worth of BIPIX shares 5 years ago would now be looking at an investment worth $1,000.
Loading charts...
Returns By Period
ProFunds Biotechnology UltraSector Fund (BIPIX) has returned 10.13% so far this year and 86.72% over the past 12 months. Over the last ten years, BIPIX has returned 7.75% per year, falling short of the S&P 500 Index benchmark, which averaged 13.61% annually.
ProFunds Biotechnology UltraSector Fund
- 1D
- 4.50%
- 1M
- -4.09%
- YTD
- 10.13%
- 6M
- 8.86%
- 1Y
- 86.72%
- 3Y*
- 5.44%
- 5Y*
- -0.00%
- 10Y*
- 7.75%
Benchmark (S&P 500 Index)
- 1D
- 0.50%
- 1M
- -0.17%
- YTD
- 8.56%
- 6M
- 8.85%
- 1Y
- 22.93%
- 3Y*
- 19.37%
- 5Y*
- 11.84%
- 10Y*
- 13.61%
BIPIX Monthly Returns History
Based on dividend-adjusted daily data since Jun 19, 2000, BIPIX's average daily return is +0.05%, while the average monthly return is +0.94%. At this rate, an investment would double in approximately 6.2 years.
Historically, 53% of months were positive and 47% were negative. The best month was Aug 2000 with a return of +32.6%, while the worst month was Dec 2024 at -33.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.
On a daily basis, BIPIX closed higher 51% of trading days. The best single day was Oct 13, 2008 with a return of +17.6%, while the worst single day was Dec 27, 2024 at -23.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.93% | 2.73% | -0.44% | 3.85% | 5.79% | -4.78% | 10.13% | ||||||
| 2025 | 3.81% | -6.78% | -13.15% | 2.32% | -7.52% | 6.67% | 4.47% | 7.00% | 17.21% | 18.96% | 13.54% | -1.43% | 47.99% |
| 2024 | -3.60% | 18.35% | -5.49% | -16.64% | 7.41% | 5.84% | 9.80% | 2.95% | -4.03% | -3.23% | 3.41% | -33.20% | -25.91% |
| 2023 | 0.35% | -6.46% | -3.04% | 7.60% | 6.90% | -2.03% | 1.39% | -9.13% | -11.55% | -14.45% | 20.65% | 26.99% | 9.55% |
| 2022 | -13.95% | -3.56% | 8.15% | -14.00% | 2.38% | -2.69% | 6.00% | -8.60% | -4.53% | 13.85% | 12.01% | -4.56% | -13.43% |
| 2021 | 8.13% | -2.67% | -0.95% | 6.54% | -0.36% | 9.50% | 5.39% | 6.45% | -10.46% | -0.06% | -2.99% | -11.01% | 5.00% |
Benchmark Metrics
ProFunds Biotechnology UltraSector Fund has an annualized alpha of 3.04%, beta of 1.35, and R2 of 0.43 versus S&P 500 Index. Calculated based on daily prices since June 19, 2000.
- This fund captured 157.37% of S&P 500 Index gains and 141.47% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.43 means the benchmark explains less than half of this fund's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 3.04%
- Beta
- 1.35
- R²
- 0.43
- Upside Capture
- 157.37%
- Downside Capture
- 141.47%
Expense Ratio
BIPIX has a high expense ratio of 1.49%, indicating above-average management fees.
Return for Risk
Risk / Return Rank
BIPIX ranks 77 for risk / return — better than 77% of mutual funds on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for ProFunds Biotechnology UltraSector Fund (BIPIX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIPIX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.36 | ||
| Sortino ratioReturn per unit of downside risk | +0.35 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.34 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 5.74 | 2.53 | +3.21 |
| Martin ratioReturn relative to average drawdown | 16.77 | 11.37 | +5.40 |
Dividends
Dividend History
ProFunds Biotechnology UltraSector Fund provided a 0.33% dividend yield over the last twelve months, with an annual payout of $0.25 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.25 | $0.25 | $0.10 | $4.13 | $0.00 | $0.55 | $8.07 | $2.03 | $2.87 | $4.49 |
Dividend yield | 0.33% | 0.37% | 0.23% | 6.69% | 0.00% | 0.79% | 12.09% | 3.26% | 5.52% | 7.19% |
Monthly Dividends
The table displays the monthly dividend distributions for ProFunds Biotechnology UltraSector Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.25 | $0.25 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 | $0.10 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.13 | $4.13 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.55 | $0.55 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the ProFunds Biotechnology UltraSector Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ProFunds Biotechnology UltraSector Fund was 84.51%, occurring on Jul 10, 2002. Recovery took 2680 trading sessions.
The current ProFunds Biotechnology UltraSector Fund drawdown is 11.76%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Dot-com crash2000–2002 | -84.51%Jul 2002 | 1y 10mo | 10y 7mo | 12y 6moSep 2000 - Mar 2013 |
2025 selloff2025 | -63.86%Apr 2025 | 3y 7mo | — | 4y 9moAug 2021 - now |
2016 bear market2016 | -45.24%Jun 2016 | 11mo 12d | 1y 7mo | 2y 6moJul 2015 - Jan 2018 |
COVID crash2020 | -36.38%Mar 2020 | 2y 1mo | 2mo 7d | 2y 4moJan 2018 - May 2020 |
2014 bear market2014 | -27.00%Apr 2014 | 1mo 15d | 4mo 5d | 5mo 20dFeb 2014 - Aug 2014 |
Drawdown Indicators
| BIPIX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.51% | -56.78% | -27.73% |
Max Drawdown (1Y)Largest decline over 1 year | -15.15% | -9.10% | -6.05% |
Max Drawdown (3Y)Largest decline over 3 years | -59.50% | -18.90% | -40.60% |
Max Drawdown (5Y)Largest decline over 5 years | -63.86% | -25.43% | -38.43% |
Max Drawdown (10Y)Largest decline over 10 years | -63.86% | -33.92% | -29.94% |
Current DrawdownCurrent decline from peak | -11.76% | -2.34% | -9.42% |
Average DrawdownAverage peak-to-trough decline | -37.19% | -10.72% | -26.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.18% | 2.02% | +3.16% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with BIPIX
Add ProFunds Biotechnology UltraSector Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BIPIX